{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:11:38Z","timestamp":1773691898645,"version":"3.50.1"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pediatric CML is very rare. Before the introduction of tyrosine kinase inhibitors (TKIs), allogeneic hematopoietic stem cell transplantation (HSCT) from a donor -if available- was the standard cure attempt. Data on the long-term outcome and health-related quality of life (HRQOL) in former pediatric CML patients undergoing HSCT are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study question<\/jats:title><jats:p>We investigated long-term survivors\u2019 self-reporting to a questionnaire sent out to patients formerly enrolled in pediatric CML-HSCT trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Individuals with CML transplanted at age &amp;lt;18 years were identified from the German Childhood Cancer Registry database. Long-term survivors received a questionnaire based on the SF-36 and FACT-BMT asking them to self-report HRQOL issues. (Ethical vote #541_20 B, Medical Faculty, University of Erlangen-N\u00fcrnberg).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>111\/171 (64.9%) individuals survived HSCT long-term and 86\/111 (77.5%) fulfilled all inclusion criteria and received the questionnaire. 37\/86 (43%) participants (24 female, 13 male, median age at HSCT 12 years [range 2-18], median age at the time of the survey 29 years [range 18-43]) responded after a median follow-up period of 19 years (range 4-27) after HSCT. 10\/37 (27%) participants underwent no regular medical follow-up examinations. Self-reported symptoms like chronic graft-versus-host disease (cGvHD)-associated organ impairments and conditioning regimen consequences could causatively not sharply be separated in each case. Complains comprised hypothyroidism (N=11, 30%), infertility (N=9, 24%), lung problems, dry eyes (each N=7, 19%), skin alterations (N=6, 17%), hair problems (N=4, 11%), and sexual dysfunction (N=3, 9%). 10 (27%) participants experienced 13 CML relapses after a median interval from HSCT of 31 months (range 2-93). Only one patient underwent 2nd SCT after failure of relapse treatment with TKIs. Six secondary malignancies (dysplastic melanocytic nevus and ALL, basal cell carcinoma (N=2), rhabdomyosarcoma, and thyroid carcinoma developed in 5 (13%) participants. As assessed by the SF-36 questionnaire, impaired physical health was mainly associated with cGvHD. The mental component summary score showed that also participants without cGvHD scored significantly lower than the general population. When assessed by the FACT-BMT, participants with cGvHD scored significantly lower while participants without cGvHD scored even 5 points higher than the data from controls. 18 (49%) participants considered the sequelae of HSCT an obstacle to education. Out of the total cohort, N=20 (54%), N=7 (19%), N=5 (14%), and N=4 (11%) participants worked full time, part-time, were unemployed, or had not yet finalized their education, respectively. 20 (54%) participants lived as singles, 8 (22%) lived in a partnership, 6 (16%) were married, and 3 (8%) had been divorced. Four (11%) participants reported a total number of 7 children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This first assessment of HRQOL in former pediatric patients with CML surviving HSCT for more than two decades demonstrates self-reported satisfactory well-being only in the absence of cGvHD. Research-based on self-reported outcomes sheds light on former patients\u2019 perspectives and provides an additional layer of valuable knowledge for pediatric and adult hematologists. Regular follow-up examinations are mandatory helping to avoid that late secondary neoplasias, CML-relapse, and disorders forming the broad range of possible long-term consequences of HSCT are not detected too late.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.963223","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:14:07Z","timestamp":1664464447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Oliver","family":"Schleicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annkathrin","family":"Horndasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Krumbholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sembill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bremensdorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Grabow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Karow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinolf","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0737-3","article-title":"The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia\u2013a report from the German registry covering the period from 1998 to 2004","volume":"88","author":"Bacher","year":"2009","journal-title":"Ann Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3032","article-title":"Children\u2019s oncology group phase 1 study. imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a children\u2019s oncology group phase 1 study","volume":"104","author":"Champagne","year":"2004","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404051","article-title":"Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation","volume":"20","author":"Millot","year":"2006","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.7740","article-title":"HLA-identical sibling compared with 8\/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia","volume":"27","author":"Arora","year":"2009","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32443","article-title":"Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A blood or marrow transplant survivor study (BMTSS) report","volume":"125","author":"Wu","year":"2019","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1239529","article-title":"Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I","volume":"221","author":"Suttorp","year":"2009","journal-title":"Klin Padiatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the bone marrow transplant survivor study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0365-4","article-title":"Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation [published online ahead of print 18 October 2018]","volume":"54","author":"Hayakawa","year":"","journal-title":"Bone Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.020","article-title":"Impact of psychological distress on quality of life, functional status, and survival in patients with chronic graft-versus-host disease","volume":"24","author":"El-Jawahri","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29651","article-title":"Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation","volume":"121","author":"Rosenberg","year":"2015","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-015-0265-2","article-title":"Quality of life in the chronic GVHD consortium cohort: lessons learned and the long road ahead","volume":"10","author":"Krupski","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000216","article-title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","volume":"134","author":"Cuvelier","year":"2019","journal-title":"Blood"},{"key":"B14","article-title":"Unrelated donor marrow transplantation in childhood: a report from the associazione italiana ematologia e oncologia pediatrica (AIEOP) and the gruppo italiano per il trapianto midollo osseo (GITMO)","volume":"87","author":"Dini","year":"2002","journal-title":"Haematologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3637","article-title":"Stem cell transplantation for chronic myeloid leukemia in children","volume":"102","author":"Cwynarski","year":"2003","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704255","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the soci\u00e9t\u00e9 fran\u00e7aise de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"32","author":"Millot","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.09.022","article-title":"Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan marrow donor program","volume":"16","author":"Muramatsu","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.02.015","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: A CIBMTR cohort analysis","volume":"22","author":"Chaudhury","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-022-03507-0","article-title":"Die kohorte der 41.000 langzeit\u00fcberlebenden des deutschen kinderkrebsregisters [The 41,000 long-term survivor cohort of the German childhood cancer registry]","volume":"65","author":"Kaatsch","year":"2022","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"B20","doi-asserted-by":"publisher","first-page":"101733","DOI":"10.1016\/j.canep.2020.101733","article-title":"Childhood cancer: Survival, treatment modalities, late effects and improvements over time","volume":"71","author":"Erdmann","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2015.0051","article-title":"Long-term follow-up after allogeneic stem cell transplantation","volume":"112","author":"Hilgendorf","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"B22","volume-title":"SF-36 pysical and mental health summary scales: A user\u2019s manual","author":"Ware","year":"1994"},{"key":"B23","volume-title":"User\u2019s manual for SF-36v2 health survey","author":"Ware","year":"2002"},{"key":"B24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02959944","article-title":"Der deutsche SF-36 health survey \u00dcbersetzung und psychometrische testung eines krankheits\u00fcbergreifenden instruments zur erfassung der gesundheitsbezogenen lebensqualit\u00e4t","volume":"3","author":"Bullinger","year":"1995","journal-title":"J Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1477-7525-4-77","article-title":"The use of the SF-36 questionnaire in adult survivors of childhood cancer: Evaluation of data quality, score reliability, and scaling assumptions","volume":"4","author":"Reulen","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"B26","article-title":"SF-36 fragebogen zum gesundheitszustand","volume-title":"Deutsche version des short form \u2013 36 health survey","author":"Morefeld","year":""},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.03.023","article-title":"Quality-of-Life trajectories in adolescent and young adult versus older adult allogeneic hematopoietic cell transplantation recipients","volume":"26","author":"Mathanda","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-502658","article-title":"Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia","volume":"122","author":"La Nasa","year":"2013","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433915","article-title":"Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system","volume":"5","author":"Bonomi","year":"1996","journal-title":"Qual Life Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310023453","article-title":"Normative data for functional assessment of cancer therapy general scale and its use for the interpretation of quality of life scores in cancer survivors","author":"Holzner","year":"2004","journal-title":"Acta Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.368","article-title":"Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation","volume":"2010","author":"Suttorp","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/bjh.12977","article-title":"Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years","volume":"167","author":"de la Fuente","year":"2014","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-648667","article-title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","volume":"127","author":"Hijiya","year":"2016","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.3","article-title":"Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study","volume":"49","author":"Bernard","year":"2014","journal-title":"Bone Marrow Transpl"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.773895","article-title":"Late effects after haematopoietic stem cell transplantation in ALL, long-term follow-up and transition: A step into adult life","volume":"9","author":"Diesch-Furlanetto","year":"2021","journal-title":"Front Pediatr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.08.004","article-title":"The impact of donor type on long-term health status and quality of life after allogeneic hematopoietic stem cell transplantation for childhood acute leukemia: A leuc\u00e9mie de l\u2019Enfant et de L\u2019Adolescent study","volume":"22","author":"Visentin","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0337-8","article-title":"Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML study","volume":"54","author":"Wilhelmsson","year":"2019","journal-title":"Bone Marrow Transpl"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i6.308","article-title":"Horn of plenty: Value of the international registry for pediatric chronic myeloid leukemia","volume":"11","author":"Suttorp","year":"2020","journal-title":"World J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04544-6","article-title":"Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study","volume":"100","author":"Dou","year":"2021","journal-title":"Ann Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1065981","article-title":"Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy","volume":"57","author":"Broglie","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12874-015-0076-0","article-title":"SwiSCI study group. participation rates, response bias and response behaviours in the community survey of the Swiss spinal cord injury cohort study (SwiSCI)","volume":"15","author":"Fekete","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11162-010-9203-2","article-title":": Can lottery incentives boost web sur vey response rates","volume":"52","author":"Laguilles","year":"2011","journal-title":"Findings Four Experiments Res Higher Educ"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/089443930101900202","article-title":"Web surveys: perceptions of burden","volume":"19","author":"Crawford","year":"2001","journal-title":"Soc Sci Comput Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41687-022-00441-2","article-title":"Association between patient factors and hospital completeness of a patient-reported outcome measures program in joint arthroplasty, a cohort study","volume":"6","author":"Harris","year":"2022","journal-title":"J Patient Rep Outcomes"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25120","article-title":"International patterns of childhood chronic myeloid leukemia: comparisons between the united states and resource-restricted nations","volume":"61","author":"Sadak","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.5.779","article-title":"Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits","volume":"10","author":"Wagner","year":"1992","journal-title":"J Clin Oncol"},{"key":"B48","first-page":"8","article-title":"Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia","volume":"21","author":"Kantarjian","year":"1994","journal-title":"Semin Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1182\/blood.V92.2.394","article-title":"Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase","volume":"92","author":"Morton","year":"1998","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.05.025","article-title":"Metabolic syndrome in Male survivors of pediatric allogeneic hematopoietic stem cell transplantation: Impact of total body irradiation, low-grade inflammation, and hypogonadism","volume":"27","author":"Muhic","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/08880018.2019.1591549","article-title":"The impact of severe late-effects after 12\u2009Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010)","volume":"36","author":"Freycon","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.06.011","article-title":"Left ventricular systolic function in long-term survivors of allogeneic hematopoietic stem cell transplantation","volume":"2","author":"Massey","year":"2020","journal-title":"JACC Cardio Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.05.009","article-title":"Male Gonadal function after allogeneic hematopoietic stem cell transplantation in childhood: A cross-sectional, population-based study","volume":"26","author":"Mathiesen","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13844","article-title":"Pediatric hematopoietic cell transplantation: Longitudinal trends in body mass index and outcomes","volume":"24","author":"Dang","year":"2020","journal-title":"Pediatr Transpl"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.0457","article-title":"Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation","volume":"30","author":"Inaba","year":"2012","journal-title":"J Clin Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2012.666781","article-title":"Final height and body mass index after fractionated total body irradiation and allogeneic stem cell transplantation in childhood leukemia","volume":"29","author":"Freycon","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.121383","article-title":"Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS study","volume":"140","author":"Wang","year":"2002","journal-title":"J Pediatr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-012-1656-3","article-title":"\u00dcbergewicht und adipositas in deutschland: Ergebnisse der studie zur gesundheit erwachsener in deutschland (DEGS1) [Overweight and obesity in Germany: results of the German health interview and examination survey for adults (DEGS1)]","volume":"56","author":"Mensink","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-022335","article-title":"Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study","volume":"109","author":"Baker","year":"2007","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2018.09.511","article-title":"Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control","volume":"13","author":"Thomas","year":"2018","journal-title":"Glob Heart."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2014.10.005","article-title":"\u201cIschemic heart disease in women: a focus on risk factors\u201d","volume":"25","author":"Mehta","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-250","article-title":"\u201cThe contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment\u201d","volume":"11","author":"Charlson","year":"2013","journal-title":"BMC Med"},{"key":"B64","unstructured":"Federal Bureau of StatisticsMicrocensus - questions on health: smoking habits of the population2017"},{"key":"B65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.17886\/RKI-GBE-2017-031","article-title":"Alkoholkonsum bei erwachsenen in deutschland: Riskante trinkmengen","volume":"2","author":"Lange","year":"2017","journal-title":"J Health Monit"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2020-0584","article-title":"Metabolic syndrome and risk factors after hematopoietic stem cell transplantation in children and adolescents","volume":"34","author":"Guner Ozenen","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2008.00420.x","article-title":"Insulin-related metabolism following hematopoietic stem cell transplantation in childhood","volume":"10","author":"Elhasid","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13060","article-title":"Survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation should undergo screening for diabetes by oral glucose tolerance tests","volume":"33","author":"Wei","year":"2016","journal-title":"Diabetes Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1536-8","article-title":"Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies","volume":"99","author":"Hirabayashi","year":"2014","journal-title":"Int J Hematol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00043426-200402000-00003","article-title":"Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation","volume":"26","author":"Hoffmeister","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12197","article-title":"New-onset post-transplant diabetes and therapy in long-term survivors after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Dalla Via","year":"2020","journal-title":"In Vivo"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.02.001","article-title":"New-onset post-transplant diabetes mellitus after allogeneic hematopoietic cell transplant is initiated by insulin resistance, not immunosuppressive medications","volume":"25","author":"Engelhardt","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2018.10.010","article-title":"Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors","volume":"133","author":"Pluimakers","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12903","article-title":"The metabolic syndrome and its components in pediatric survivors of allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Bielorai","year":"2017","journal-title":"Clin Transplant"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2018-0020","article-title":"Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning","volume":"31","author":"Cima","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.032","article-title":"Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies","volume":"15","author":"Savani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.04.031","article-title":"Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant","volume":"63","author":"Faraci","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2020_200214N131","article-title":"Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood","volume":"67","author":"Keslova","year":"2020","journal-title":"Neoplasma"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.39","article-title":"Poor growth, thyroid dysfunction and vitamin d deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults","volume":"51","author":"Myers","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-173005","article-title":"Thyroid function following hematopoietic cell transplantation in children: 30 years\u2019 experience","volume":"113","author":"Sanders","year":"2009","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26028","article-title":"Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia","volume":"63","author":"Samis","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1159\/000514381","article-title":"Long-term follow-up of children, adolescents, and young adult cancer survivors","volume":"44","author":"Hilgendorf","year":"2021","journal-title":"Oncol Res Treat"},{"key":"B83","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pcl.2009.11.003","article-title":"Chronic graft-versus-host disease (GVHD) in children","volume":"57","author":"Baird","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"B84","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-02278-5_44","article-title":"Chronic graft-Versus-Host disease","volume-title":"The EBMT handbook: Hematopoietic stem cell transplantation and cellular therapies","author":"Wolff","year":"2019"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.70","article-title":"Comorbidity burden in patients with chronic GVHD","volume":"48","author":"Wood","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.07.017","article-title":"Diagnosis and staging of chronic graft-versus-host disease in the clinical practice","volume":"17","author":"Greinix","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2016_511","article-title":"The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study","volume":"63","author":"Valkova","year":"2016","journal-title":"Neoplasma"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.43","article-title":"Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up","volume":"50","author":"Wilhelmsson","year":"2015","journal-title":"Bone Marrow Transpl"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.01.022","article-title":"Systematic review of patient-reported outcome measures in graft-versus-Host disease","volume":"26","author":"Kilgour","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.05.001","article-title":"Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Yoshihara","year":"2007","journal-title":"Biol Blood Marrow Transpl"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.06.005","article-title":"Lung function after allogeneic hematopoietic stem cell transplantation in children: a longitudinal study in a population-based cohort","volume":"19","author":"Uhlving","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"key":"B92","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V82.10.3211.3211","article-title":"Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. chronic leukemia working party. European bone marrow transplantation group","volume":"82","author":"Arcese","year":"1993","journal-title":"Blood"},{"key":"B93","article-title":"Chronic leukemia working party of the European group for blood and marrow transplantation. allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. an analysis by the chronic leukemia working party of the European group for blood and marrow transplantation (EBMT)","volume":"91","author":"Gratwohl","year":"2006","journal-title":"Haematologica"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2045985","DOI":"10.1155\/2018\/2045985","article-title":"Chronic myeloid leukemia relapsing 25 years after allogenic stem cell transplantation","volume":"2018","author":"Reikvam","year":"2018","journal-title":"Case Rep Hematol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000839","article-title":"Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases","volume":"4","author":"Kahn","year":"2020","journal-title":"Blood Adv"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpedi.2018.05.023","article-title":"Neoplasias malignas secundarias despu\u00e9s de un trasplante de progenitores hematopoy\u00e9ticos en edad pedi\u00e1trica [Subsequent malignancies after long-term follow-up of pediatric hematopoietic stem cell transplantation]","volume":"90","author":"Sisinni","year":"2019","journal-title":"Pediatr (Engl Ed)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.012","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European group for blood and marrow transplantation, the center for international blood and marrow transplant research, and the American society of blood and marrow transplantation","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transpl"},{"key":"B98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2018.07.006","article-title":"PanCareSurFup, ENCCA working group; ExPo-r-Net working group. the \u2018Survivorship passport\u2019 for childhood cancer survivors","volume":"102","author":"Haupt","year":"2018","journal-title":"Eur J Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.03.023","article-title":"ASBMT practice guidelines committee survey on long-term follow-up clinics for hematopoietic cell transplant survivors","volume":"24","author":"Hashmi","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.01.003","article-title":"National cancer institute, national heart, lung and blood Institute\/Pediatric blood and marrow transplantation consortium first international consensus conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines","volume":"18","author":"Pulsipher","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: A children\u2019s oncology group report","volume":"22","author":"Chow","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"key":"B102","article-title":"Side effects and sequelae of treatment for chronic myeloid leukemia in childhood and adolescence","volume-title":"Late treatment effects and cancer survivor care in the young: - from childhood to early adulthood","author":"Suttorp","year":"2020"},{"key":"B103","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbmt.2010.10.023","article-title":"Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors","volume":"17","author":"Khera","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"B104","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/bloodadvances.2018026039","article-title":"High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation","volume":"3","author":"Miyamura","year":"2019","journal-title":"Blood Adv"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.11.003","article-title":"Predictors of loss to follow-up among pediatric and adult hematopoietic cell transplantation survivors: A report from the center for international blood and marrow transplant research","volume":"26","author":"Buchbinder","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000681","article-title":"Caring for survivors of childhood cancer: it takes a village","volume":"30","author":"Song","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1177\/0009922813483361","article-title":"Reviewing the follow-up care of pediatric patients\u2019 status post-hematopoietic stem cell transplantation for the primary care pediatrician","volume":"52","author":"Jesudas","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"key":"B110","volume-title":"Autorenkollektiv","year":"2022"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2013.829541","article-title":"Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning","volume":"31","author":"Freycon","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.688965","article-title":"Childhood leukemia and its impact on graduation and having children: results from a national survey","volume":"53","author":"Zynda","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"B113","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/pbc.22806","article-title":"Educational and vocational achievement among long-term survivors of adolescent cancer in Germany","volume":"56","author":"Dieluweit","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B114","volume-title":"Daten und Fakten: Arbeitslosigkeit","author":"Sell","year":""},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31781","article-title":"Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the center for international blood and marrow transplant research (CIBMTR)","volume":"125","author":"Bhatt","year":"2019","journal-title":"Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-03058-7","article-title":"Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study","volume":"113","author":"Soejima","year":"2021","journal-title":"Int J Hematol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.135","article-title":"The experience of survival following allogeneic haematopoietic stem cell transplantation in new south Wales, Australia","volume":"51","author":"Gifford","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.253","article-title":"Quality of life and social integration after allogeneic hematopoietic SCT","volume":"42","author":"Bieri","year":"2008","journal-title":"Bone Marrow Transpl"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0343-x","article-title":"Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey","volume":"54","author":"Kurosawa","year":"2019","journal-title":"Bone Marrow Transpl"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24519","article-title":"Self-reported quality of life in long-term survivors of childhood lymphoblastic malignancy treated with hematopoietic stem cell transplantation versus conventional therapy","volume":"60","author":"Sundberg","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.78","article-title":"Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence","volume":"47","author":"Borgmann-Staudt","year":"2012","journal-title":"Bone Marrow Transpl"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01642-9","article-title":"Nature\u2019s endless wonder: unexpected motherhood after pediatric allogeneic stem cell transplantation and severe late effects","volume":"132","author":"Bauer","year":"2020","journal-title":"Wien Klin Wochenschr"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705364","article-title":"Francisco, L: Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study","volume":"37","author":"Carter","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05482-4","article-title":"Soci\u00e9, G: Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey","volume":"358","author":"Salooja","year":"2001","journal-title":"Lancet"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","article-title":"Levy, W: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation","volume":"87","author":"Sanders","year":"1996","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab199","article-title":"Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT pediatric diseases working party","volume":"36","author":"Diesch-Furlanetto","year":"2021","journal-title":"Hum Reprod"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.147","article-title":"Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the pediatric diseases working party of the EBMT and the international BFM study group","volume":"52","author":"Balduzzi","year":"2017","journal-title":"Bone Marrow Transpl"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.21","article-title":"State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the paediatric diseases working party (PDWP) of the European society for blood and marrow transplantation (EBMT) in Baden, Austria, 29-30 September 2015","volume":"52","author":"Dalle","year":"2017","journal-title":"Bone Marrow Transpl"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-021-00656-y","article-title":"Health-related quality of life of patients with chronic myeloid leukemia as measured by patient-reported outcomes: Current state and future directions","volume":"16","author":"Schoenbeck","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704638","article-title":"A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase","volume":"34","author":"Hayden","year":"2004","journal-title":"Bone Marrow Transpl"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2214.2010.01182.x","article-title":"Clinical outcomes and health-related quality of life (HRQOL) following haemopoietic stem cell transplantation (HSCT) for paediatric leukaemia","volume":"37","author":"Clarke","year":"2011","journal-title":"Child Care Health Dev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.01316","article-title":"Quality of life and psychopathology in adults who underwent hematopoietic stem cell transplantation (HSCT) in childhood: A qualitative and quantitative analysis","volume":"8","author":"Sinatora","year":"2017","journal-title":"Front Psychol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/petr.12713","article-title":"Physical and emotional well-being of survivors of childhood and young adult allo-SCT - a Danish national cohort study","volume":"20","author":"Jensen","year":"2016","journal-title":"Pediatr Transpl"}],"updated-by":[{"DOI":"10.3389\/fonc.2022.1116757","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.963223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T14:43:29Z","timestamp":1671115409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.963223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":133,"alternative-id":["10.3389\/fonc.2022.963223"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.963223","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fonc.2022.1116757","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"963223"}}